246 related articles for article (PubMed ID: 16127367)
1. Central N-acetyl aspartylglutamate deficit: a possible pathogenesis of schizophrenia.
Tsai SJ
Med Sci Monit; 2005 Sep; 11(9):HY39-45. PubMed ID: 16127367
[TBL] [Abstract][Full Text] [Related]
2. NAAG, NMDA receptor and psychosis.
Bergeron R; Coyle JT
Curr Med Chem; 2012; 19(9):1360-4. PubMed ID: 22304714
[TBL] [Abstract][Full Text] [Related]
3. The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes.
Kolodziejczyk K; Hamilton NB; Wade A; Káradóttir R; Attwell D
Brain; 2009 Jun; 132(Pt 6):1496-508. PubMed ID: 19383832
[TBL] [Abstract][Full Text] [Related]
4. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains.
Tsai G; Passani LA; Slusher BS; Carter R; Baer L; Kleinman JE; Coyle JT
Arch Gen Psychiatry; 1995 Oct; 52(10):829-36. PubMed ID: 7575102
[TBL] [Abstract][Full Text] [Related]
5. Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.
Zuo D; Bzdega T; Olszewski RT; Moffett JR; Neale JH
J Biol Chem; 2012 Jun; 287(26):21773-82. PubMed ID: 22570482
[TBL] [Abstract][Full Text] [Related]
6. Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder.
Reynolds LM; Reynolds GP
J Psychiatr Res; 2011 Jan; 45(1):54-9. PubMed ID: 20684832
[TBL] [Abstract][Full Text] [Related]
7. Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors.
Olszewski RT; Wegorzewska MM; Monteiro AC; Krolikowski KA; Zhou J; Kozikowski AP; Long K; Mastropaolo J; Deutsch SI; Neale JH
Biol Psychiatry; 2008 Jan; 63(1):86-91. PubMed ID: 17597589
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic drugs increase N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells.
Arun P; Madhavarao CN; Moffett JR; Namboodiri AM
J Neurochem; 2008 Aug; 106(4):1669-80. PubMed ID: 18631215
[TBL] [Abstract][Full Text] [Related]
9. Morphology and ultrastructure of rat hippocampal formation after i.c.v. administration of N-acetyl-L-aspartyl-L-glutamate.
Pliss L; Balcar VJ; Bubeníková V; Pokorný J; Fitzgibbon T; St'astný F
Neuroscience; 2003; 122(1):93-101. PubMed ID: 14596851
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia.
Gehl LM; Saab OH; Bzdega T; Wroblewska B; Neale JH
J Neurochem; 2004 Aug; 90(4):989-97. PubMed ID: 15287905
[TBL] [Abstract][Full Text] [Related]
11.
Morland C; Nordengen K
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163193
[No Abstract] [Full Text] [Related]
12. N-acetylaspartylglutamate (NAAG) is the probable mediator of axon-to-glia signaling in the crayfish medial giant nerve fiber.
Gafurov B; Urazaev AK; Grossfeld RM; Lieberman EM
Neuroscience; 2001; 106(1):227-35. PubMed ID: 11564432
[TBL] [Abstract][Full Text] [Related]
13. NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat.
Zhong C; Zhao X; Van KC; Bzdega T; Smyth A; Zhou J; Kozikowski AP; Jiang J; O'Connor WT; Berman RF; Neale JH; Lyeth BG
J Neurochem; 2006 May; 97(4):1015-25. PubMed ID: 16606367
[TBL] [Abstract][Full Text] [Related]
14. N-Acetylated alpha-linked acidic dipeptidase converts N-acetylaspartylglutamate from a neuroprotectant to a neurotoxin.
Thomas AG; Vornov JJ; Olkowski JL; Merion AT; Slusher BS
J Pharmacol Exp Ther; 2000 Oct; 295(1):16-22. PubMed ID: 10991955
[TBL] [Abstract][Full Text] [Related]
15. The Good and Bad Sides of NAAG.
Khacho P; Wang B; Bergeron R
Adv Pharmacol; 2016; 76():311-49. PubMed ID: 27288081
[TBL] [Abstract][Full Text] [Related]
16. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.
Olszewski RT; Bukhari N; Zhou J; Kozikowski AP; Wroblewski JT; Shamimi-Noori S; Wroblewska B; Bzdega T; Vicini S; Barton FB; Neale JH
J Neurochem; 2004 May; 89(4):876-85. PubMed ID: 15140187
[TBL] [Abstract][Full Text] [Related]
17. NAAG inhibits KCl-induced [(3)H]-GABA release via mGluR3, cAMP, PKA and L-type calcium conductance.
Zhao J; Ramadan E; Cappiello M; Wroblewska B; Bzdega T; Neale JH
Eur J Neurosci; 2001 Jan; 13(2):340-6. PubMed ID: 11168538
[TBL] [Abstract][Full Text] [Related]
18. Separate N-acetyl aspartyl glutamate, N-acetyl aspartate, aspartate, and glutamate quantification after pediatric mild traumatic brain injury in the acute phase.
Menshchikov P; Ivantsova A; Manzhurtsev A; Ublinskiy M; Yakovlev A; Melnikov I; Kupriyanov D; Akhadov T; Semenova N
Magn Reson Med; 2020 Dec; 84(6):2918-2931. PubMed ID: 32544309
[TBL] [Abstract][Full Text] [Related]
19. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
